Crewe Advisors LLC

Position in DXCM — Dexcom Inc

CIK 1730033 SALT LAKE CITY, UT

Position in DXCM

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$3,434

+$1,550 QoQ

Shares Held

+70.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#884

of 966 holders

Holding Since

Sep 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Crewe Advisors LLC holds $616,207 across 13 Medical Devices names. DXCM ranks #12 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	1,106	$348,213
2	ABT	Abbott Laboratories	902	$81,847
3	GEHC	GE HealthCare Technologies Inc.	777	$49,735
4	MDT	Medtronic plc	523	$40,914
5	BSX	Boston Scientific Corp	663	$28,296
6	LIVN	LivaNova PLC	204	$16,774
7	UFPT	Ufp Technologies Inc	61	$16,172
8	ZBH	Zimmer Biomet Holdings, Inc.	146	$12,569

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,434	51	+70.0%	Shares	Sole	2026-07-24
2026-03-31	$1,884	30	+328.6%	Shares	Sole	2026-05-07
2025-12-31	$464	7	+40.0%	Shares	Sole	2026-01-16
2025-06-30	$436	5	-97.5%	Shares	Sole	2025-07-30
2024-09-30	$13,609	203	0.0%	Shares	Sole	2024-11-12
2024-06-30	$23,016	203	-3.3%	Shares	Sole	2024-07-29
2024-03-31	$29,127	210	+467.6%	Shares	Sole	2024-05-14
2023-06-30	$4,754	37	-83.1%	Shares	Sole	2023-07-28
2023-03-31	$25,443	219	-22.1%	Shares	Sole	2023-05-12
2022-12-31	$31,820	281	-25.3%	Shares	Sole	2023-02-08
2022-09-30	$30,283	376	+8.0%	Shares	Sole	2022-11-14
2022-06-30	$25,936	348	+8600.0%	Shares	Sole	2022-08-02
2021-09-30	$2,187	4	0.0%	Shares	Sole	2021-10-29
2021-06-30	$1,708	4	0.0%	Shares	Sole	2021-08-11
2021-03-31	$1,437	4	0.0%	Shares	Sole	2021-04-21
2020-12-31	$1,478	4	-42.9%	Shares	Sole	2021-01-27
2020-09-30	$2,885	7	—	Shares	Sole	2020-10-13
No filing history on record for this holder in this stock.